Efficacy and safety studies as the main advantage

Abela Pharm, PropoMucil, ATS International Conference, Dallas, USA, 2019.

Abela Pharm, importance of intestinal microbiota, International Conference, Ayia Napa, Cyprus, 2019.

Abela Pharm, PropoMucil, ATS International Conference, San Diego, USA, 2018.

Abela Pharm, importance of intestinal microbiota, International Conference, Sicily, Italy, 2018.

Abela Pharm, PropoMucil, ATS International Conference, Washington DC, USA, 2017.

Abela Pharm, Herbafast fiber, 30th ECNP Congress, Paris, France, 2017.

Abela Pharm, importance of intestinal microbiota, International Conference, Istria, Croatia, 2017.

Abela Pharm, Bulardi, Digestive Disease Week, San Diego, USA, 2016.

PropoMucil capsules Abela Pharm study: ATM

Randomized, double blind, placebo controlled study of efficacy and safety of propolis and N-acetylcysteine in contrast to a placebo group of adults and kids with acute respiratory conditions with heavy mucus formation in the airways, Dejan Žujović PhD, Lidija Sagić PhD; City center for tuberculosis and Lung diseases, Belgrade.

ARTEROprotect Abela Pharm study:

Jelena Jovanovic, Aleksandra Jesic, Anita Agic, Vladan Djordjevic. Efficiency of Use of Dietary Supplement Arteroprotect® In Prevention of Cardiovascular Diseases. International Journal of Pharmaceutical Science Invention ISSN (Online): 2319 – 6718, ISSN (Print): 2319 – 670X www.ijpsi.org Volume 6 Issue 2, February 2017 ‖ PP. 17-20.

Bulardi Abela Pharm study: DDW

Prophylactic use of Saccharomyces probiotic in preventing antibiotic-associated diarrhea. Place: Clinic of Dr Dragiša Mišović – Dedinje, Authors: Nikola Panic MD, Maja Tufegdzic MD, Stefania Boccia PhD, Marija Stokic, Milutin Bulajic PhD. Epidemiology, Biostatistics and Public Health

Tensilen Abela Pharm study

“Efficacy of Herbiko’s Tensilen as an adjuvant to antidepressant therapy in treating mild to moderate depression cases”, Slavica Đukić Dejanović PhD, prof., Đokić Gorica MD, Psychiatric Institute „Dr Laza Lazarević“

Herbafast Fiber Abela Pharm study

G.M. Djokic, V. Djordjevic, A. Agic, A. Rankovic, P. Vojvodic, S. Djukic Dejanovic. The effects of Nutriose- Glucomannan- antioxidant complex on the parameters of the metabolic syndrome in the SCH patients treated with olanzapine. 30th ECNP Congress, 2-5. September, 2017, Paris, France.P.3.b.003

Herbiko Abela Pharm study:

Zivkovic Z et al. The experience with herbal preparation in the treatment of cough in children. Medical Herald, Timok. 40; no. 4 (2015), pgs. 248-258.

Bulardi Abela Pharm study:

Spuran M. et al The Use of Probiotic Monoculture Saccharomyces boulardii in Maintaining Health of Digestive System. MD- Medical Data 2017;9(3): 167-170.

Bulardi/ Flobian Abela Pharm study

Peric S.et al. Doctor’s experience at different levels of health care in the clinical use of probiotic monocultures. MD-Medical Data 2017; 9(1):057-061.

Bulardi Junior Abela Pharm study:

Mirjana Stojsic. Modern Aspects of using Saccharomyces boulardii in Paediatric Clinical Practice. Preventive paediatrics, number 2. April 2017; 3(1-2): 70-74.

Flobian, Abela Pharm study:

Aleksandar Pavlovic, Vladan Djordjevic, Predrag Dugalic. The efficicency of use of probiotic monoculture Lactobacillus plantarum 299v/Lp299v in maintaining the health of digestive system. Health protection. 2017;3:54-61. UDK numbers 615.246.03

PropoMucil Abela Pharm study:

Ostojic O., Prijic A., Zivkovic Z. Natural Products For the Cough Treatment in Children – PropoMucil. Children’s Hospital for Lung Diseases, HCC „Dr Dragisa Misovic-Dedinje“. Expected in Preventive Paediatrics, Number 4. March 2018.

CardioVitamin Abela Pharm study:

Jelena Jovanovic, Аnita Agic, Vladan Dordevic. Efficacy of dietary supplement use in arterial hypertension prevention. Health and safety. Number 2. June 2017. 67-72.

PropoMucil Abela Pharm study:

Aleksandra Bajec-Opancina, Vladan Subarevic, Katarina Stankovic, Mladen Novkovic, Vladan Djordjevic. Comparative Study of PropoMucil® For the Treatment of Acute Respiratory Infections of the Upper Respiratory Tract in Children. Preventive pediatrics, 2017; 3(1-2) : 63-69.

PropoMucil Abela Pharm study:

Sagic L, Milosevic K, Ugrinic-Sklopic B, Agic A. Propolis and N-Acetylcysteine For the Treatment of Acute Respiratory Infections in Children. SAPO VIII, Zlatibor, Serbia, May 2017.

PropoMucil Abela Pharm study:

Folic M, Nesic V, Arsovic N. PropoMucil® Preparations For the Treatment of Hypertrophic Adenoids, Secretory Otitis Media and Allergic Rhinitis in Children. SAPO VIII, Zlatibor, Serbia, May 2017.

PropoMucil Abela Pharm study:

Bajec-Opancina, et al. Comparative Study of PropoMucil® For the Treatment of Acute Respiratory Infections of the Upper Respiratory Tract in Children. Proceedings, 4th Multidisciplinary Symposium, 2017:167-179.

PropoMucil Abela Pharm study:

Bajec-Opancina A. et al. Efficiency of Propolis and N- Acetylcysteine for the Treatment of Acute Respiratory Infections in Children.MD- Medical Data 2017;9(3): 149-153.

PropoMucil Abela Pharm study:

Agic A, Korcok D, Lazovic B. Herbal medicine in acute respiratory infections. Medical Data. Expected in Dec 2017